XML 78 R19.htm IDEA: XBRL DOCUMENT
v3.19.3

Impairment of Long-Lived Assets | 9 Months Ended
--- | ---
Sep. 30, 2019
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract] |
Impairment of Long-Lived Assets |
12. | Impairment of Long-Lived Assets
The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See discussion of the Company’s long-lived asset impairment evaluation process in Note 1 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K. As noted in the discussion, fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the nine months ended September 30, 2019 and 2018. As of September 30, 2019, the estimated aggregate fair value of the long-lived assets impaired during the nine months ended September 30, 2019 was $27,383. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Below is a summary of impairment charges for the periods presented:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |
U.S. theatre properties and equipment |  | $ | 24,502 |  |  | $ | 1,553 |  |  | $ | 26,754 |  |  | $ | 3,331 |
U.S. operating lease right-of-use assets |  |  | 2,157 |  |  |  | — |  |  |  | 10,204 |  |  |  | — |
International theatre properties and equipment |  |  | 645 |  |  |  | 88 |  |  |  | 6,796 |  |  |  | 1,689 |
International operating lease right-of-use assets |  |  | — |  |  |  | — |  |  |  | 1,628 |  |  |  | — |
Total |  | $ | 27,304 |  |  | $ | 1,641 |  |  | $ | 45,382 |  |  | $ | 5,020 |

X
- Definition The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported. + References No definition available. + Details
Name: | us-gaap_AssetImpairmentChargesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ImpairmentOrDisposalOfTangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration